For example, some studies have shown that tumor HLA-DQB1 level is associated with the recurrence free survival (RFS) of early Lung Adenocarcinoma, and the mechanism may be related to anti-tumor immunity (Zhang et al., 2019). This evidence concerns the gene HLA-DQB1 and lung adenocarcinoma.